|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61K 35/17 | (2025.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61P 35/02 | (2006.01) | ||
| A61K 39/00 | (2006.01) |
| (11) | Number of the document | 4051710 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20800121.4 |
| Date of filing the European patent application | 2020-10-30 | |
| (97) | Date of publication of the European application | 2022-09-07 |
| (45) | Date of publication and mention of the grant of the patent | 2025-11-26 |
| (46) | Date of publication of the claims translation | 2026-03-10 |
| (86) | Number | PCT/EP2020/080494 |
| Date | 2020-10-30 |
| (87) | Number | WO 2021/084063 |
| Date | 2021-05-06 |
| (30) | Number | Date | Country code |
| 19206479 | 2019-10-31 | EP |
| (72) |
ENDELL, Jan , DE
BOXHAMMER, Rainer , DE
PRETSCHER, Dominik , DE
|
| (73) |
Incyte Corporation ,
1801 Augustine Cut-Off, Wilmington, DE 19803,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Priešnavikinė kompleksinė terapija, apimanti anti-CD19 antikūną ir gama delta ląsteles |
| ANTI-TUMOR COMBINATION THERAPY COMPRISING ANTI-CD19 ANTIBODY AND GAMMA DELTA T-CELLS |